Back to search

Article

Combining multi-omics and drug perturbation profiles to identify novel treatments that improve disease phenotypes in spinal muscular atrophy

2019-12-18

Abstract excerpt

<h4>ABSTRACT</h4> Spinal muscular atrophy (SMA) is a neuromuscular disorder caused by loss of survival motor neuron (SMN) protein. While SMN restoration therapies are beneficial, they are not a cure. We aimed to identify novel treatments to alleviate muscle pathology combining transcriptomics, proteomics and perturbational datasets. This revealed potential drug candidates for repurposing in SMA. One of the lead c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b174ff62-ebbf-5ca1-8918-63499f9123f1
DOI
10.1101/2019.12.17.879353
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Combining multi-omics and drug perturbation profiles to identify novel treatments that improve disease phenotypes in spinal muscular atrophyDOI 10.1101/2019.12.17.879353
Select a neighboring publication to make it the new centre.